Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Dose decrease
Total 0 results
Nothing found
Sponsors and Collaborators
Chien Yu Huang
Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
Our Lady of Lourdes Hospital Waregem
Saitama Medical University International Medical Center
Agricultural University of Athens
Luxembourg Centre for Systems Biomedicine
Jen Ai Hospital
Giresun University
Enas Sayed Farhat
Perosphere Technologies
Hospital for Sick Kids
Shengyun Lin
Amy Fu
National Institute of Mental Health (NIMH)
Rizki Darmawan
The Leeds Teaching Hospitals Charitable Foundation
Park-Klinik Berlin Weißensee
PORTAL CDRN
Adriaan Dirk van der Wart
EdiGene Inc.
View Full List
Medical Conditions
Chronic Conjunctivitis of Both Eyes
Complication of Transplanted Lung
Acute Malnutrition
Fasting Mimicking Diet
Arginase 1 Deficiency
Esophageal High-Grade Intraepithelial Neoplasia
Premature Retinopathy
Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level
Non-small Cell Lung Cancer Stage II
HİP FRACTURE
Respiratory Distress Syndrome, Infant
Macular Degeneration (Age Related)
Intermediate-high Risk
Illness Related Work
Employee Health
Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma
Congenital Valgus Foot Deformity
Oral Mucosal Anesthesia
Defecatory Functions
Patient With Cardiovascular-kidney-metabolic Syndrome
View Full List
Drug Interventions
Lurasidone
Capecitabine
Empagliflozin
1/2Ganyan1
NEOK001
Nitazoxanide 500Mg Oral Tablet
Participants assigned to this arm received injection nalbuphine.
RiBVD
CVL-562 (PF-06412562) 4 mg
Betrixaban
AKB-6548
Heparin
Clindamycin Gel
Human protein C concentrate
Tenofovir Alafenamide 25 MG for arm (A)
Albuterol HFA (Armstrong's)
Rivaroxaban
AK112 Injection
Two tablets of EHCV in Single Dose each tablet containing SOF 200 mg, RBV 500 mg and Natural anti-hemolytic (AH) at 200 mg
Etoricoxib
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Benin
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Cambodia
Contract Research Organizations in Ecuador
Contract Research Organizations in Ghana
Contract Research Organizations in India
Contract Research Organizations in Lithuania
Contract Research Organizations in Mauritania
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Taiwan
Contract Research Organizations in Trinidad & Tobago
Contract Research Organizations in Uganda
CRO list by country
CROs in Portugal
SanaClis
VectorB2B
W4Research
Alpha Bioresearch
PPD
IQVIA
Pivotal
Fortrea
Blueclinical
SGS
All CROs in Portugal
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe